PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 158 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q3 2021 | $13,000 | -23.5% | 1,864 | 0.0% | 0.00% | – |
| Q2 2021 | $17,000 | -64.6% | 1,864 | -62.0% | 0.00% | – |
| Q1 2021 | $48,000 | -4.0% | 4,904 | 0.0% | 0.00% | – |
| Q4 2020 | $50,000 | +2.0% | 4,904 | 0.0% | 0.00% | – |
| Q3 2020 | $49,000 | -3.9% | 4,904 | 0.0% | 0.00% | – |
| Q2 2020 | $51,000 | +240.0% | 4,904 | +172.4% | 0.00% | – |
| Q1 2020 | $15,000 | -37.5% | 1,800 | -33.3% | 0.00% | – |
| Q4 2019 | $24,000 | -17.2% | 2,699 | 0.0% | 0.00% | – |
| Q3 2019 | $29,000 | -14.7% | 2,699 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | -69.6% | 2,699 | -6.9% | 0.00% | -100.0% |
| Q1 2019 | $112,000 | +89.8% | 2,899 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $59,000 | -55.6% | 2,899 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $133,000 | -22.2% | 2,899 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $171,000 | -13.2% | 2,899 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | -39.6% | 2,899 | -12.1% | 0.00% | -33.3% |
| Q4 2017 | $326,000 | +6.5% | 3,299 | +28.9% | 0.00% | 0.0% |
| Q3 2017 | $306,000 | +229.0% | 2,559 | +141.6% | 0.00% | +200.0% |
| Q2 2017 | $93,000 | +210.0% | 1,059 | +33.0% | 0.00% | – |
| Q1 2017 | $30,000 | +25.0% | 796 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -54.7% | 796 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $53,000 | +165.0% | 796 | +19.5% | 0.00% | – |
| Q2 2016 | $20,000 | 0.0% | 666 | 0.0% | 0.00% | – |
| Q1 2016 | $20,000 | -61.5% | 666 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $52,000 | -64.6% | 666 | -66.0% | 0.00% | -50.0% |
| Q3 2015 | $147,000 | -35.5% | 1,957 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $228,000 | +635.5% | 1,957 | +1405.4% | 0.00% | – |
| Q1 2015 | $31,000 | – | 130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 507,500 | $121,074,000 | 24.90% |
| BB BIOTECH AG | 476,991 | $113,796,000 | 4.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $1,356,668,000 | 3.35% |
| WEATHERBIE CAPITAL, LLC | 101,055 | $24,109,000 | 2.26% |
| Avalon Global Asset Management LLC | 16,000 | $3,817,000 | 2.24% |
| Redmile Group, LLC | 51,025 | $12,173,000 | 1.41% |
| Fernwood Investment Management, LLC | 6,700 | $1,598,000 | 1.38% |
| Iguana Healthcare Management, LLC | 10,000 | $2,386,000 | 1.27% |
| LMR Partners LLP | 56,632 | $13,510,000 | 1.08% |
| FRANKLIN STREET ADVISORS INC /NC | 21,990 | $5,246,000 | 1.00% |